Identify predictive biomarkers of sensitivity to Pol I inhibition
This study seeks to identify biomarkers predicting sensitivity to RNA Polymerase I (Pol I) inhibition to enhance patient stratification and treatment outcomes in cancer therapy.
Student intake
This project is open for Honours, Masters and PhD students.
Group
Research theme
Research themes
Project status
Project status
Potential
Contact
Contact
Content navigation
About
This study aims to identify predictive biomarkers that indicate sensitivity to RNA Polymerase I (Pol I) inhibition. By analyzing biomarkers associated with response to Pol I inhibitors, the research seeks to improve patient stratification and treatment outcomes in cancer therapy.
Members
Supervisor
Group Leader
Deputy Dean, Research, CHM
NHMRC Principle Res. Fellow
Senior Fellow